ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32837-10mg |
|
464-74-4 |
Arenobufagin
|
0 | C24H32O6 | |
GC32837-5mg |
|
464-74-4 |
Arenobufagin
|
0 | C24H32O6 | |
GC32837-10mM(1mLinDMSO) |
|
464-74-4 |
Arenobufagin
|
0 | C24H32O6 | |
GC32836-50mg |
|
1448237-05-5 |
Naquotinib mesylate (ASP8273)
|
0 | C31H46N8O6S | |
GC32836-25mg |
|
1448237-05-5 |
Naquotinib mesylate (ASP8273)
|
0 | C31H46N8O6S | |
GC32836-10mg |
|
1448237-05-5 |
Naquotinib mesylate (ASP8273)
|
0 | C31H46N8O6S | |
GC32836-5mg |
|
1448237-05-5 |
Naquotinib mesylate (ASP8273)
|
0 | C31H46N8O6S | |
GC32836-1mg |
|
1448237-05-5 |
Naquotinib mesylate (ASP8273)
|
0 | C31H46N8O6S | |
GC32836-10mM(1mLinDMSO) |
|
1448237-05-5 |
Naquotinib mesylate (ASP8273)
|
0 | C31H46N8O6S | |
GC32835-50mg |
|
212391-58-7 |
PP58
|
0 | C22H19Cl2N5O2 | |
GC32835-10mg |
|
212391-58-7 |
PP58
|
0 | C22H19Cl2N5O2 | |
GC32835-5mg |
|
212391-58-7 |
PP58
|
0 | C22H19Cl2N5O2 | |
GC32835-1mg |
|
212391-58-7 |
PP58
|
0 | C22H19Cl2N5O2 | |
GC32835-10mM(1mLinDMSO) |
|
212391-58-7 |
PP58
|
0 | C22H19Cl2N5O2 | |
GC32834-2mg |
|
497871-47-3 |
Lurbinectedin (PM01183)
|
0 | C41H44N4O10S | |
GC32834-1mg |
|
497871-47-3 |
Lurbinectedin (PM01183)
|
0 | C41H44N4O10S | |
GC32833-100mg |
|
1430218-51-1 |
VI 16832
|
0 | C22H25N5O2 | |
GC32833-50mg |
|
1430218-51-1 |
VI 16832
|
0 | C22H25N5O2 | |
GC32833-10mg |
|
1430218-51-1 |
VI 16832
|
0 | C22H25N5O2 | |
GC32833-5mg |
|
1430218-51-1 |
VI 16832
|
0 | C22H25N5O2 | |